Researchers at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center are leading a number of studies in osteosarcoma, a type of cancer that starts in the bones.
Robert Johnson remains in remission more than three years after participating in a pioneering immunotherapy clinical trial for his stage IV adenocarcinoma non-small cell lung cancer.
Targeted therapies take aim at the specific genetic changes and the proteins within cancer cells that drive their chaotic growth.
Making a nutritious meal doesn’t always have to be time-consuming. Here's how you can maximize your efforts in the kitchen.
Keith Rohleder was diagnosed with a rare, aggressive blood cancer that most people have never heard of. But a new clinical trial put him into remission.
Cancer is common, in short, because genetic changes are common.
A diet high in whole grains, fruits, and vegetables, along with exercise and maintaining a healthy body weight can improve the five-year survival rate for patients with stage III colorectal cancer, according to a new report from Dana-Farber Cancer Institute researchers.
New technologies are being used to analyze exactly how DIPG develops in the first place.
Scientists are making headway in understanding the basic biological mechanisms at work in inflammatory breast cancer (IBC)—and how to intervene in ways that may slow or stop the cancer.
Assessing a multiple myeloma patient’s predicted outcome and risk through genetic analysis can enable tailored treatment for individual patients.
One doctor had initially forecast that Acra Samuels had no more than six months to live. Targeted treatment through Dana-Farber has almost certainly extended her life significantly.
A growing arsenal of new drugs that unleash the body’s immune system against tumors has captured the cancer treatment spotlight.
Nutritionists and doctors agree that consuming soft drinks in excess is associated with several health complications and diseases, including weight gain or obesity, poor dental health, diabetes, cardiovascular disease and more. Some of these health conditions can play a role in increasing one’s risk of developing cancer.
An interventional radiology procedure stabilized the growth of a toddler’s rare liver tumor until he was able to receive a life-saving liver transplant. Today, he is healthy and thriving.
CAR T-cell therapy—a form of immunotherapy that uses genetically engineered T cells to intensify the immune system's response to cancer—represents one of the biggest advances against cancer in recent years.
Cutaneous lymphoma is a rare subtype of non-Hodgkin lymphoma that starts in the skin.
In 2009, Drew was diagnosed with aplastic anemia, a rare blood disorder. Because of a stem cell transplant, he was cured—and now, he has his mind set on becoming a pediatric oncologist.
Findings from clinical trials have increased survival rates significantly in the last several decades for children with germ cell tumors.
Recent drug approvals collectively mark a new era in the treatment of adults with these diseases, scientists say.
Radiation therapy, or radiotherapy, is often one component of treatment for gynecologic malignancies such as cervical, vaginal, and endometrial cancer.
Make An Appointment
For adults: 877-960-1562
Quick access: Appointments as soon as the next day for new adult patients
For children: 888-733-4662
Get a Weekly Insight Email
Most Read Stories
Patient and Family Blogs
Patients and families of patients at Dana-Farber often chronicle their own experiences with cancer.